Efficient replication systems for hepatitis C virus using a new human hepatoma cell line

Virus Research

Volumn 146, Issue 1-2, 2009, Pages 41-50

  Kato, Nobuyuki ^a   Mori, Kyoko ^a   Abe, Ken ichi ^a   Dansako, Hiromichi ^a   Kuroki, Misao ^a   Ariumi, Yasuo ^a   Wakita, Takaji ^b   Ikeda, Masanori ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

HCV RNA replication; Hepatitis C virus (HCV); Infectious HCV production; Li23 cells; Reporter assay for anti HCV reagents

Indexed keywords

COMPLEMENTARY DNA; CORE PROTEIN; REAGENT; VIRUS RNA;

ADULT; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIFE CYCLE; MALE; MICROARRAY ANALYSIS; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; REPLICON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING;

CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; HEPACIVIRUS; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED;

HEPATITIS C VIRUS;

EID: 70350233422     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.08.006     Document Type: Article

References (43)

1. Abe K., Ikeda M., Dansako H., Naka K., and Kato N. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA. Virus Res. 125 (2007) 88-97
2. Ali S., Pellerin C., Lamarre D., and Kukolj G. Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line. J. Virol. 78 (2004) 491-501
3. Ariumi Y., Kuroki M., Abe K., Dansako H., Ikeda M., Wakita T., and Kato N. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J. Virol. 81 (2007) 13922-13926
4. Ariumi Y., Kuroki M., Dansako H., Abe K., Ikeda M., Wakita T., and Kato N. The DNA damage sensors, ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication. J. Virol. 82 (2008) 9639-9646
5. Bartenschlager R., and Sparacio S. Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. Virus Res. 127 (2007) 195-207
6. Blight K.J., McKeating J.A., and Rice C.M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76 (2002) 13001-13014
7. Burlone M.E., and Budkowska A. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J. Gen. Virol. 90 (2009) 1055-1070
8. Chevaliez S., and Pawlotsky J.M. Interferon-based therapy of hepatitis C. Adv. Drug Deliv. Rev. 59 (2007) 1222-1241
9. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
10. Dansako H., Naganuma A., Nakamura T., Ikeda F., Nozaki A., and Kato N. Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Res. 97 (2003) 17-30
11. Date T., Kato T., Miyamoto M., Zhao Z., Yasui K., Mizokami M., and Wakita T. Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells. J. Biol. Chem. 279 (2004) 22371-22376
12. Gottwein J.M., and Bukh J. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems. Adv. Virus Res. 71 (2008) 51-133
13. Hadziyannis S.J., Sette, Morgan T.R., Balan V., Diago M., Marcellin P., Ramadori G., Bodenheimer, Bernstein D., Rizzetto M., Zeuzem S., Pockros P.J., Lin A., and Ackrill A.M. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 140 (2004) 346-355
14. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., and Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5547-5551
15. Hijikata M., Mizushima H., Tanji Y., Komoda Y., Hirowatari Y., Akagi T., Kato N., Kimura K., and Shimotohno K. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 10773-10777
16. Ikeda M., Abe K., Dansako H., Nakamura T., Naka K., and Kato N. Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem. Biophys. Res. Commun. 329 (2005) 1350-1359
17. Ikeda M., Abe K., Yamada M., Dansako H., Naka K., and Kato N. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology 44 (2006) 117-125
18. Ikeda M., and Kato N. Modulation of host metabolism as a target of new antivirals. Adv. Drug Deliv. Rev. 59 (2007) 1277-1289
19. Ikeda M., Sugiyama K., Mizutani T., Tanaka T., Tanaka K., Sekihara H., Shimotohno K., and Kato N. Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus. Virus Res. 56 (1998) 157-167
20. Ikeda M., Yi M., Li K., and Lemon S.M. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J. Virol. 76 (2002) 2997-3006
21. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., and Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 9524-9528
22. Kato N., Nakazawa T., Mizutani T., and Shimotohno K. Susceptibility of human T-lymphotropic virus type 1 infected cell line MT-2 to hepatitis C virus infection. Biochem. Biophys. Res. Commun. 206 (1995) 863-869
23. Kato N., and Shimotohno K. Systems to culture hepatitis C virus. Curr. Top. Microbiol. Immunol. 242 (2000) 261-278
24. Kato N., Sugiyama K., Namba K., Dansako H., Nakamura T., Takami M., Naka K., Nozaki A., and Shimotohno K. Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro. Biochem. Biophys. Res. Commun. 306 (2003) 756-766
25. Kato T., Date T., Miyamoto M., Furusaka A., Tokushige K., Mizokami M., and Wakita T. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125 (2003) 1808-1817
26. Kishine H., Sugiyama K., Hijikata M., Kato N., Takahashi H., Noshi T., Nio Y., Hosaka M., Miyanari Y., and Shimotohno K. Subgenomic replicon derived from a cell line infected with the hepatitis C virus. Biochem. Biophys. Res. Commun. 293 (2002) 993-999
27. Kuroki M., Ariumi Y., Ikeda M., Dansako H., Wakita T., and Kato N. Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stress. J. Virol. 83 (2009) 2338-2348
28. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
29. Lindenbach B.D., and Rice C.M. Unravelling hepatitis C virus replication from genome to function. Nature 436 (2005) 933-938
30. Lohmann V., Körner F., Koch J., Herian U., Theilmann L., and Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285 (1999) 110-113
31. Matto M., Rice C.M., Aroeti B., and Glenn J.S. Hepatitis C virus core protein associates with detergent-resistant membranes distinct from classical plasma membrane rafts. J. Virol. 78 (2004) 12047-12053
32. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., and Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9 (2007) 1089-1097
33. Mori K., Abe K., Dansako H., Ariumi Y., Ikeda M., and Kato N. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C. Biochem. Biophys. Res. Commun. 371 (2008) 104-109
34. Moriishi K., and Matsuura Y. Evaluation systems for anti-HCV drugs. Adv. Drug Deliv. Rev. 59 (2007) 1213-1221
35. Murakami K., Kimura T., Osaki M., Ishii K., Miyamura T., Suzuki T., Wakita T., and Shoji I. Virological characterization of the hepatitis C virus JFH-1 strain in lymphocytic cell lines. J. Gen. Virol. 89 (2008) 1587-1592
36. Nishimura G., Ikeda M., Mori K., Nakazawa T., Ariumi Y., Dansako H., and Kato N. Replicons from genotype 1b HCV-positive sera exhibit diverse sensitivities to anti-HCV reagents. Antiviral Res. 82 (2009) 42-50
37. Pietschmann T., Lohmann V., Kaul A., Krieger N., Rinck G., Rutter G., Strand D., and Bartenschlager R. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J. Virol. 76 (2002) 4008-4021
38. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi Y., Watanabe Y., Koi S., Onji M., Ohta Y., Choo Q.L., Houghton M., and Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6547-6549
39. Thomas D.L. Hepatitis C epidemiology. Curr. Top. Microbiol. Immunol. 242 (2000) 25-41
40. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Kräusslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
41. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 9294-9299
42. Zhu H., Dong H., Eksioglu E., Hemming A., Cao M., Crawford J.M., Nelson D.R., and Liu C. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology 133 (2007) 1649-1659
43. Zhu Q., Guo J.T., and Seeger C. Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J. Virol. 77 (2003) 9204-9210